U.S. pharma giant copyright scrapped two experimental weight loss drugs very last 12 months—a at the time-day-to-day capsule, lotiglipron, as a result of elevated liver enzymes and also a 2 times-every day pill, danuglipron, as a result of powerful Unintended effects—but CEO Albert Bourla has said the company is decided to “play and gain” w